Medical treatment of silent myocardial ischemia

P F Cohn1

  • 1Cardiology, State University of New York, Health Sciences Center at Stony Brook, Stony Brook, New York 11794-8171, USA.

Insights

Silent ischemia, common in coronary artery disease, affects prognosis. While drug therapy can reduce ischemic burden and improve outcomes, coronary revascularization offers greater benefits.

Area of Science:

  • Cardiology
  • Ischemic Heart Disease

Background:

  • Silent myocardial ischemia is highly prevalent in patients with coronary artery disease.
  • The underlying pathophysiology of silent ischemia is not fully understood.
  • Silent ischemia negatively impacts patient prognosis, regardless of symptoms.

Purpose of the Study:

  • To review the detection, prognosis, and therapeutic strategies for silent ischemia in coronary artery disease.
  • To highlight the role of Holter monitoring in assessing silent ischemia during daily activities.

Main Methods:

  • Review of current literature on silent ischemia detection and management.
  • Discussion of stress testing and Holter monitoring as diagnostic tools.
  • Evaluation of pharmacologic and revascularization therapies for silent ischemia.

Main Results:

  • Holter monitoring is effective for detecting ischemia during daily life and evaluating treatment efficacy.
  • Both pharmacologic agents and coronary artery revascularization can reduce ischemic burden.
  • Coronary revascularization demonstrates a more significant improvement in prognosis compared to pharmacologic therapy.

Conclusions:

  • Silent ischemia is a significant predictor of adverse outcomes in coronary artery disease patients.
  • Therapeutic interventions, particularly revascularization, can improve prognosis in patients with silent ischemia.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...